John Adeyemo Adedeji

Dr. John Adeyemo Adedeji


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2026 in ChemRxiv
Verified
Preprint
Open access
JAJohn Adeyemo Adedeji
John Adeyemo Adedeji
Computational drug discovery is often narrated as a series of revolutions, each new architecture rendering the last obsolete. This review instead reads six decades of the field, from Hansch and Fujita's 1964 QSAR framework to current diffusion and foundation models, as a single methodological lineage in which later tools extend and absorb earlier ones rather than replace them outright. Five major methodological transitions are examined against the relationship between data availability and method adoption, yielding a specific pattern rather than a general orientation: three transitions, the rise of structure-based design, the shift to broadly applicable machine-learning QSAR, and the current wave of structure-conditioned generative methods, were gated by prior or concurrent expansion of data infrastructure (the Protein Data Bank, ChEMBL, and the AlphaFold Database respectively), while two, the shift from linear regression to non-linear ensemble methods and the 2012 deep learning inflection, were driven primarily by architectural innovation with data availability playing a secondary role. Antimicrobial resistance is used throughout as a stress test, since its combination of target novelty, data sparsity, and evolving resistance mechanisms exposes where each generation of methods has, and has not, generalised, and two documented successes, halicin and abaucin, are examined in detail alongside the downstream synthetic and toxicological attrition that followed their identification. Data debt, meaning unrepresentative, sparse, and inequitably distributed training data, particularly for infectious disease and low-resource contexts, emerges as a persistent constraint that architectural progress alone has not resolved. Seven open problems are identified, most concerning data, validation, and governance rather than model design, and a specific, testable comparison is proposed by which the relative contribution of data scale versus architectural advance could be assessed directly using existing AMR data consortia.

3 July 2025 in BioHackrXiv
Verified
Preprint
Open access
MDMichał Denkiewicz
Michał Denkiewicz
RARahaf M. Ahmad
Rahaf M. Ahmad
RGRishika Gupta
Rishika Gupta
SGSachin Gadakh
Sachin Gadakh
JKJędrzej Kubica
Jędrzej Kubica
BBBen Busby
Ben Busby
The BioAI Hackathon at the Centre of New Technologies at the University of Warsaw convened 43 international researchers to collaboratively explore artificial intelligence (AI) approaches for solving complex challenges in computational biology. Nine interdisciplinary and multi-institutional teams addressed the following problems: disease-gene prioritization, microbiome analysis, drug-protein interactions, alternative splicing prediction, chromatin architecture study and toxicological profiling. Using cutting-edge tools such as graph neural networks (GNNs), large language models (LLMs), and multi-omics integration frameworks, participants developed scalable and reproducible analytical pipelines. The results include: a disease gene prioritization framework using GNNs, a microbiome dynamics analysis for poultry health prediction and the construction of chromatin structure-aware regulatory networks. All projects follow the open science principles and display translational potential. This hackathon underscores the transformative role of AI in biomedicine and the value of collaborative, time-bounded innovation for accelerating discovery in life sciences. All projects are publicly available on GitHub: https://github.com/SFGLab

Verified
Journal Article
Open access
PDF file
ECEmele Udochukwu Cosmas
Emele Udochukwu Cosmas
JAJohn Adeyemo Adedeji
John Adeyemo Adedeji
Benign prostatic hyperplasia (BPH) is a histological diagnosis defined by unregulated proliferation of connective tissue, smooth muscle, and glandular epithelium within the prostate gland